// App-Quantinova.ai

Su1397 : Outpatients With Ulcerative Colitis Being Treated With Adalimumab and Infliximab Have Similar Rates of Loss of Response

Researchers

Presenter

  • Christopher Ma

Principal Investigators

  • Darryl K. Fedorak

  • Karen I. Kroeker

  • Levinus A. Dieleman

  • Richard N. Fedorak

Medical Centers

  • Division of Hematology, University of Alberta, Edmonton, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Oraprine

  • Methotrexate

  • Adalimumab

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved